Biomarkers – News and Features

News
NCI Announces $35 Million in Awards
These Awards will establish 12 Cancer Nanotechnology Platform Partnerships.

News
Ingenuity Technology Licensed by SPRI
Ingenuity Pathways Analysis 3.0 enables biologists and bioinformaticians to model, analyze, and understand the complex biological systems.

News
Power3 Medical's CSO to Address OncoProteomics World Congress;
Goldknopf to Present Results on Breast Cancer and Leukemia and to Join Conference Scientific Advisory Board.

News
Ciphergen, UCL, and UCL BioMedica Sign Collaboration Agreement
Ciphergen and its collaborators will work together to further validate and characterize ovarian cancer biomarkers.

News
Nanowires Can Detect Molecular Signs of Cancer
The minuscule devices promise to pinpoint the exact type of cancer present.

News
Merck Signs Research and Drug Development Agreement with FoxHollow
The collaboration will help in identifying biomarkers of atherosclerotic disease progression for use in the development of cardiovascular compounds in Merck's pipeline.

News
Icoria Receives Notice of Allowance on Tissue Analysis Patent
Allowed patent covers measurement of several tissue structure features for high-throughput screening.

News
Collaborations to Develop Applications Using HyperSense DNP Technology for NMR
Researchers will use HyperSense™ to identify biological markers for cancer, to develop methods for determining the kinetics and dynamics of protein-ligand interactions and for rapid characterization of compound libraries.

News
Clinical Data to Acquire Icoria
Clinical Data will acquire Icoria in an all-stock transaction valued at approximately $12.5 million based on the closing price of Clinical Data’s Common Stock on Friday, September 16.

News
Positive Beta Site Results for Sequenom's iPLEX™ Assay Trigger Multiple Sales
Sequenom's iPLEX assay is very useful for evaluating targeted sets of SNPs and also expedites follow up work in the validation of genome scan results.
Advertisement